ANAB logo

AnaptysBio, Inc. (ANAB)

Profile

Full Name

AnaptysBio, Inc.

Ticker

NASDAQ: ANAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 26, 2017

Indexes

Not included

Website

https://www.anaptysbio.com

Employees

136

Key Details

Price

$36.00(3.63%)

Market Cap

$996.79M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$91.28M(432.03% YoY)

Annual EPS

-$5.12(15.80% YoY)

PE Ratio

-

Next earnings date

Feb 26, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $36.00
    ANAB price is $36.00

    30-Day Relative Volume

    1.50
    ANAB 30-day relative volume is 1.50

    Price Performance

    Price Most Recent Change

    +3.63%
    ANAB price was up +3.63% on Nov 5, 2025

    Price YTD Change

    +171.9%
    ANAB price is up +171.9% since January 1st

    Price 1-Year Change

    +62.09%
    ANAB price is up +62.09% year-on-year

    Price 3-Year Change

    +21.33%
    ANAB price is up +21.33% over the past 3 years

    Price Range

    Price All-Time High

    $134.00
    ANAB price is currently -73.13% below its historical high of $134.00

    Price 3-Year Low

    $12.21
    ANAB price is currently +194.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $996.79M
    ANAB market cap is $996.79 million

    Market Cap 3-Year Change

    +18.16%
    ANAB market cap is up +18.16% over the past 3 years

    Market Cap All-Time High

    $3.06B
    ANAB market cap is currently -67.43% below its historical high of $3.06 billion

    Market Cap Sector Percentile

    71.29%
    ANAB market cap is higher than 71.29% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -9.01%
    ANAB shares outstanding is down -9.01% year-on-year

    Shares Outstanding 3-Year Change

    -2.61%
    ANAB shares outstanding is down -2.61% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.72
    ANAB beta is 0.72

    200-day SMA

    $22.33
    ANAB price is currently +61.24% above its 200-day simple moving average

    50-day SMA

    $28.07
    ANAB price is currently +28.26% above its 50-day simple moving average

    14-Day RSI

    65.56
    ANAB 14-day relative strength index is 65.56

    Volume

    1.50
    ANAB 30-day relative volume is 1.50

    ATR

    $2.00
    ANAB average true range is $2.00

    10-day Historical Volatility

    35.73%
    ANAB 10-day historical volatility is 35.73%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $91.28M
    ANAB annual revenue is $91.28 million

    Revenue Analysts Estimate

    $133.64M
    ANAB annual revenue is currently -31.70% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +432.03%
    ANAB annual revenue is up +432.03% year-on-year

    Revenue Sector Percentile

    67.79%
    ANAB annual revenue is higher than 67.79% of companies in Healthcare sector

    EPS

    EPS

    -$5.12
    ANAB annual earnings per share is -$5.12

    EPS Analysts Estimate

    -$4.17
    ANAB annual earnings per share is currently -22.66% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +15.8%
    ANAB annual earnings per share is up +15.8% year-on-year

    EPS Sector Percentile

    20.39%
    ANAB annual earnings per share is higher than 20.39% of companies in Healthcare sector

    Profit

    Gross Profit

    $88.88M
    ANAB annual gross profit is $88.88 million

    Gross Margin

    97.37%
    ANAB annual gross profit margin is 97.37%

    Operating Profit

    -$114.95M
    ANAB annual operating income is -$114.95 million

    Operating Margin

    -125.93%
    ANAB annual operating profit margin is -125.93%

    Net Income

    -$145.23M
    ANAB annual net profit is -$145.23 million

    Net Margin

    -159.11%
    ANAB annual net profit margin is -159.11%

    Expenses

    Total Expenses

    $206.23M
    ANAB annual total expenses is $206.23 million

    Operating Expenses

    $206.23M
    ANAB annual total operating expenses is $206.23 million

    Cost Of Goods Sold

    $2.40M
    ANAB annual cost of goods sold is $2.40 million

    Selling, General & Administrative Expenses

    $42.39M
    ANAB annual SG&A is $42.39 million

    Depreciation & Amortization

    $2.40M
    ANAB annual D&A is $2.40 million

    Interest Expense

    $50.09M
    ANAB annual interest expense is $50.09 million

    Income Tax

    $3000.00
    ANAB annual income tax is $3000.00

    EBIT & EBITDA

    EBIT

    -$95.14M
    ANAB annual earnings before interest & taxes is -$95.14 million

    EBITDA

    -$92.74M
    ANAB annual EBITDA is -$92.74 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $483.83M
    ANAB annual total assets is $483.83 million

    Non Current Assets

    $51.96M
    ANAB annual long term assets is $51.96 million

    Current Assets

    $431.88M
    ANAB annual total current assets is $431.88 million

    Cash and Cash Equivalents

    $123.08M
    ANAB annual cash & cash equivalents is $123.08 million

    Accounts Receivable

    $40.77M
    ANAB annual accounts receivable is $40.77 million

    Inventory

    $0.00
    ANAB annual inventory is $0.00

    Liabilities

    Total Liabilities

    $412.97M
    ANAB annual total liabilities is $412.97 million

    Long Term Liabilities

    $367.54M
    ANAB annual total long term liabilities is $367.54 million

    Current Liabilities

    $45.43M
    ANAB annual current liabilities is $45.43 million

    Accounts Payable

    $4.00M
    ANAB annual accounts payable is $4.00 million

    Debt

    Total Debt

    $369.46M
    ANAB annual total debt is $369.46 million

    Total Debt 1-Year Change

    +12.43%
    ANAB annual total debt is up +12.43% year-on-year

    Long Term Debt

    $367.54M
    ANAB annual long term debt is $367.54 million

    Short Term Debt

    $1.93M
    ANAB annual short term debt is $1.93 million

    Equity & Capital

    Shareholders Equity

    $70.87M
    ANAB annual stockholders equity is $70.87 million

    Book Value

    $70.87M
    ANAB annual book value is $70.87 million

    Retained Earnings

    -$759.33M
    ANAB annual retained earnings is -$759.33 million

    Working Capital

    $386.45M
    ANAB annual working capital is $386.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$135.34M
    ANAB annual cash from operations is -$135.34 million

    Cash From Operations 1-Year Change

    -12.03%
    ANAB annual cash from operations is down -12.03% year-on-year

    Cash From Investing

    $95.40M
    ANAB annual cash from investing is $95.40 million

    Cash From Investing 1-Year Change

    -34.1%
    ANAB annual cash from investing is down -34.1% year-on-year

    Cash From Financing

    $127.05M
    ANAB annual cash from financing is $127.05 million

    Cash From Financing 1-Year Change

    +314.27%
    ANAB annual cash from financing is up +314.27% year-on-year

    CAPEX

    CAPEX

    $358.00K
    ANAB annual capital expenditures is $358.00 thousand

    CAPEX 1-Year Change

    -55.64%
    ANAB annual capital expenditures is down -55.64% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$135.69M
    ANAB annual free cash flow is -$135.69 million

    Free Cash Flow 1-Year Change

    -11.58%
    ANAB annual free cash flow is down -11.58% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    97.37%
    ANAB annual gross profit margin is 97.37%

    Operating Margin

    -125.93%
    ANAB annual operating profit margin is -125.93%

    Net Margin

    -159.11%
    ANAB annual net profit margin is -159.11%

    ROA & ROE

    ROA

    -31.02%
    ANAB annual return on assets is -31.02%

    ROE

    -182.71%
    ANAB annual return on equity is -182.71%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ANAB price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ANAB price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -22.28
    ANAB price to book ratio is -22.28

    PB Ratio Sector Percentile

    2.79%
    ANAB price to book ratio is higher than 2.79% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    8.09
    ANAB price to sales ratio is 8.09

    PS Ratio Sector Percentile

    67.73%
    ANAB price to sales ratio is higher than 67.73% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.08B
    ANAB enterprise value is $1.08 billion

    Enterprise Value Sector Percentile

    73.14%
    ANAB enterprise value is higher than 73.14% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -12.87
    ANAB EV/EBITDA is -12.87

    EV/EBITDA Sector Percentile

    11.42%
    ANAB EV/EBITDA is higher than 11.42% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    9.51
    ANAB annual current ratio is 9.51

    Quick Ratio

    9.51
    ANAB annual quick ratio is 9.51

    Leverage

    Debt To Equity

    0.00
    ANAB annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -1.90
    ANAB annual interest coverage ratio is -1.90

    Risk & Stability

    F-Score

    4
    ANAB piotroski f-score is 4

    Altman Z-Score

    -0.25
    ANAB altman z-score is -0.25

    Analyst ratings

    Recent major analysts updates

    Nov 5, 25 Wells Fargo
    Overweight
    Nov 5, 25 Guggenheim
    Buy
    Oct 29, 25 Stifel
    Buy
    Oct 15, 25 Wedbush
    Outperform
    Oct 13, 25 Barclays
    Overweight
    Sep 30, 25 Wedbush
    Outperform
    Sep 30, 25 HC Wainwright & Co.
    Buy
    Aug 12, 25 UBS
    Neutral
    Aug 7, 25 Wedbush
    Outperform
    Jul 24, 25 JP Morgan
    Overweight

    Institutional Ownership

    Screeners with ANAB included

    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for AnaptysBio, Inc.?
    • Does AnaptysBio, Inc. pay dividends?
    • What sector is AnaptysBio, Inc. in?
    • What industry is AnaptysBio, Inc. in?
    • What country is AnaptysBio, Inc. based in?
    • When did AnaptysBio, Inc. go public?
    • Is AnaptysBio, Inc. in the S&P 500?
    • Is AnaptysBio, Inc. in the NASDAQ 100?
    • Is AnaptysBio, Inc. in the Dow Jones?
    • When was AnaptysBio, Inc.'s last earnings report?
    • When does AnaptysBio, Inc. report earnings?

    What is the ticker symbol for AnaptysBio, Inc.?

    The ticker symbol for AnaptysBio, Inc. is NASDAQ:ANAB

    Does AnaptysBio, Inc. pay dividends?

    No, AnaptysBio, Inc. does not pay dividends

    What sector is AnaptysBio, Inc. in?

    AnaptysBio, Inc. is in the Healthcare sector

    What industry is AnaptysBio, Inc. in?

    AnaptysBio, Inc. is in the Biotechnology industry

    What country is AnaptysBio, Inc. based in?

    AnaptysBio, Inc. is headquartered in United States

    When did AnaptysBio, Inc. go public?

    AnaptysBio, Inc.'s initial public offering (IPO) was on January 26, 2017

    Is AnaptysBio, Inc. in the S&P 500?

    No, AnaptysBio, Inc. is not included in the S&P 500 index

    Is AnaptysBio, Inc. in the NASDAQ 100?

    No, AnaptysBio, Inc. is not included in the NASDAQ 100 index

    Is AnaptysBio, Inc. in the Dow Jones?

    No, AnaptysBio, Inc. is not included in the Dow Jones index

    When was AnaptysBio, Inc.'s last earnings report?

    AnaptysBio, Inc.'s most recent earnings report was on November 4, 2025

    When does AnaptysBio, Inc. report earnings?

    The next expected earnings date for AnaptysBio, Inc. is February 26, 2026
    On this page